David Aufrere Oxlade
Presidente en Oxford Gene Technology Ltd. .
Perfil
David Aufrere Oxlade currently works at Oxford Gene Technology Ltd., as Chairman, Oxford Gene Technology IP Ltd., as Director, and Oxford Gene Technology (Operations) Ltd., as Director from 2016.
Mr. Oxlade also formerly worked at Xenova Group Plc, as Chief Executive Officer, BioAnaLab Ltd., as Chairman, Base4 Innovation Ltd., as Chairman, Kirkstall Ltd., as Chairman, TranScrip Partners LLP, as Chairman, Oxford Cancer Biomarkers Ltd., as Non-Executive Chairman, Cobra Biologics Holdings Ltd., as Non-Executive Director from 2006 to 2010, Syva Co., as President, and Roche Diagnostics GmbH, as President.
Cargos activos de David Aufrere Oxlade
Empresas | Cargo | Inicio |
---|---|---|
Oxford Gene Technology Ltd.
Oxford Gene Technology Ltd. Miscellaneous Commercial ServicesCommercial Services Oxford Gene Technology Ltd. develops arrays used in genomics research. It engages in providing services to the pharmaceutical and other sectors in making DNA arrays known as in-situ synthesis of oligonucleotide robes. The company was founded by Edwin Southern in 1995 and is headquartered in Begbroke, the United Kingdom. | Presidente | - |
Oxford Gene Technology IP Ltd.
Oxford Gene Technology IP Ltd. BiotechnologyHealth Technology Part of Sysmex Corp., Oxford Gene Technology IP Ltd. is a British company that engages in research and experimental development on biotechnology. The company is based in Begbroke, UK. | Director/Miembro de la Junta | - |
Oxford Gene Technology (Operations) Ltd.
Oxford Gene Technology (Operations) Ltd. Pharmaceuticals: MajorHealth Technology Part of Sysmex Corp., Oxford Gene Technology (Operations) Ltd. is a holding British company that operates subsidiaries which develop, manufacture, and market molecular genetics. The company is based in Begbroke, UK and was founded in 1999. | Director/Miembro de la Junta | 25/02/2016 |
Antiguos cargos conocidos de David Aufrere Oxlade.
Empresas | Cargo | Fin |
---|---|---|
Kirkstall Ltd.
Kirkstall Ltd. Pharmaceuticals: OtherHealth Technology Kirkstall Ltd. provides in vitro cell culture research and the development services. Its products include cancer research, stem cell research, disease modeling, drug discovery and advanced organ models. The company was founded by J. Malcolm Wilkinson, Garry P. Mumford, and Arti Ahluwalia on November 23, 2006 and is headquartered in Rotherham, the United Kingdom. | Presidente | - |
Cobra Biologics Holdings Ltd.
Cobra Biologics Holdings Ltd. BiotechnologyHealth Technology Cobra Biomanufacturing Plc manufactures biological products for clinical studies and clients in the pharmaceutical and biotech industries. It designs and manufactures novel proteins, viruses and additional cell products. It provides DNA-based technologies, services and products. Its services include: DNA, virus and protein manufacturing, cell banking, process development, analytical services and quality assurance and regulatory support. It uses mammalian and microbial host cells for numerous therapeutic protein developments. It also provides a range of DNA maintenance technology, such as its ORT, ORT-VAC and RiboCLEAR programs. The company is headquartered in Newcastle, the United Kingdom. | Director/Miembro de la Junta | 05/03/2010 |
Oxford Cancer Biomarkers Ltd.
Oxford Cancer Biomarkers Ltd. Hospital/Nursing ManagementHealth Services Oxford Cancer Biomarkers Ltd. provides cancer treatment services. It offers a suite of drug-specific companion diagnostic kits that allow the biomarker to be directly measured in tumor biopsies or patient DNA and thereby patients that respond favorably to the drug identified. The company was founded by David Kerr and Nick LaThangue in 2012 and is headquartered in Oxford, the United Kingdom. | Presidente | - |
Base4 Innovation Ltd.
Base4 Innovation Ltd. Medical SpecialtiesHealth Technology Base4 Innovation Ltd. develops single molecule detection platforms for healthcare and life sciences. The firm develops DNA sequencing using techniques based on silicon chip technology which can easily be scaled up and this high-throughput technology will cut the time and cost of genetic tests, enabling them to be used much more in patient diagnosis and treatment. The company was founded by Cameron Alexander Frayling in 2007 and is headquartered in Cambridge, the United Kingdom. | Presidente | - |
TranScrip Partners LLP
TranScrip Partners LLP Pharmaceuticals: MajorHealth Technology TranScrip Partners LLP is a consultancy provider for biotech and pharmaceutical companies. TranScrip Partners was founded in 2008 and is based in Wokingham, UK. The British company offers development and commercialization services to its clients. | Presidente | - |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas privadas | 12 |
---|---|
Cobra Biologics Holdings Ltd.
Cobra Biologics Holdings Ltd. BiotechnologyHealth Technology Cobra Biomanufacturing Plc manufactures biological products for clinical studies and clients in the pharmaceutical and biotech industries. It designs and manufactures novel proteins, viruses and additional cell products. It provides DNA-based technologies, services and products. Its services include: DNA, virus and protein manufacturing, cell banking, process development, analytical services and quality assurance and regulatory support. It uses mammalian and microbial host cells for numerous therapeutic protein developments. It also provides a range of DNA maintenance technology, such as its ORT, ORT-VAC and RiboCLEAR programs. The company is headquartered in Newcastle, the United Kingdom. | Health Technology |
BioAnaLab Ltd.
BioAnaLab Ltd. Miscellaneous Commercial ServicesCommercial Services BioAnaLab Ltd. offered biologic drug and vaccine analysis. It provided scientific and clinical insight with meticulous attention to regulatory compliance and on-time delivery. The company was founded by Stephen Cobbold, Geoff Hale and Peppy Rebello in 2002 and was headquartered in Oxford, the United Kingdom. | Commercial Services |
Xenova Group Plc
Xenova Group Plc Miscellaneous Commercial ServicesCommercial Services Xenova Group Plc researches and develops pharmaceutical products. The company is focused on the development of novel drugs to treat cancer and addiction with a secondary focus in immunotherapy. It has pipeline of drug candidates in clinical development including a novel program for the treatment of high-grade glioma and TransMID. The company was founded in 1987 and is headquartered in Slough, UK | Commercial Services |
Syva Co. | |
Roche Diagnostics GmbH
Roche Diagnostics GmbH Miscellaneous Commercial ServicesCommercial Services Part of Roche Holding AG, Roche Diagnostics GmbH is a German company that develops innovative medicines, treatments, and diagnostics. The company is based in Mannheim, Germany. The CEOs of the company are Claudia Fleischer, Claus Haberda, Clemens Schmid. Roche Diagnostics was acquired by Roche Holding AG on January 01, 1999. | Commercial Services |
Kirkstall Ltd.
Kirkstall Ltd. Pharmaceuticals: OtherHealth Technology Kirkstall Ltd. provides in vitro cell culture research and the development services. Its products include cancer research, stem cell research, disease modeling, drug discovery and advanced organ models. The company was founded by J. Malcolm Wilkinson, Garry P. Mumford, and Arti Ahluwalia on November 23, 2006 and is headquartered in Rotherham, the United Kingdom. | Health Technology |
TranScrip Partners LLP
TranScrip Partners LLP Pharmaceuticals: MajorHealth Technology TranScrip Partners LLP is a consultancy provider for biotech and pharmaceutical companies. TranScrip Partners was founded in 2008 and is based in Wokingham, UK. The British company offers development and commercialization services to its clients. | Health Technology |
Base4 Innovation Ltd.
Base4 Innovation Ltd. Medical SpecialtiesHealth Technology Base4 Innovation Ltd. develops single molecule detection platforms for healthcare and life sciences. The firm develops DNA sequencing using techniques based on silicon chip technology which can easily be scaled up and this high-throughput technology will cut the time and cost of genetic tests, enabling them to be used much more in patient diagnosis and treatment. The company was founded by Cameron Alexander Frayling in 2007 and is headquartered in Cambridge, the United Kingdom. | Health Technology |
Oxford Cancer Biomarkers Ltd.
Oxford Cancer Biomarkers Ltd. Hospital/Nursing ManagementHealth Services Oxford Cancer Biomarkers Ltd. provides cancer treatment services. It offers a suite of drug-specific companion diagnostic kits that allow the biomarker to be directly measured in tumor biopsies or patient DNA and thereby patients that respond favorably to the drug identified. The company was founded by David Kerr and Nick LaThangue in 2012 and is headquartered in Oxford, the United Kingdom. | Health Services |
Oxford Gene Technology Ltd.
Oxford Gene Technology Ltd. Miscellaneous Commercial ServicesCommercial Services Oxford Gene Technology Ltd. develops arrays used in genomics research. It engages in providing services to the pharmaceutical and other sectors in making DNA arrays known as in-situ synthesis of oligonucleotide robes. The company was founded by Edwin Southern in 1995 and is headquartered in Begbroke, the United Kingdom. | Commercial Services |
Oxford Gene Technology IP Ltd.
Oxford Gene Technology IP Ltd. BiotechnologyHealth Technology Part of Sysmex Corp., Oxford Gene Technology IP Ltd. is a British company that engages in research and experimental development on biotechnology. The company is based in Begbroke, UK. | Health Technology |
Oxford Gene Technology (Operations) Ltd.
Oxford Gene Technology (Operations) Ltd. Pharmaceuticals: MajorHealth Technology Part of Sysmex Corp., Oxford Gene Technology (Operations) Ltd. is a holding British company that operates subsidiaries which develop, manufacture, and market molecular genetics. The company is based in Begbroke, UK and was founded in 1999. | Health Technology |
- Bolsa de valores
- Insiders
- David Aufrere Oxlade